Mitov Vladimir, Perisić Zoran, Jolić Aleksandar, Adamović Dragana, Zastranović Lale, Aleksić Aleksandar, Kostić Tomislav, Božinović Nenad, Aleksić Zeljka, Soldatović Ivan
Department of Cardiology, Medical center Zaječar, Rasadnicka bb, 19000 Zaječar, Serbia.
Hell J Nucl Med. 2013 Sep-Dec;16(3):204-8.
Our aim was to analyze any changes during diastole in patients with normal left ventricular ejection fraction (LVEF), after pacemaker stimulation from the right ventricular outflow tract (RVOT) and right ventricular apex (RVA) lead position. This was a prospective, randomized, follow up study, which lasted for 12 months. Our research included 132 consecutive patients who were implanted with a permanent antibradycardiac pacemaker. Regarding the right ventricle lead position the patients were divided into two groups: The RVOT group--71 patients, with right ventricle outflow tract lead position and the RVA group--61 patients, with right ventricle apex lead position. We measured LVEF and diastolic parameters: peak filling ratio and time to peak filling ratio obtained by radionuclide ventriculography (RNV). The LVEF and various diastolic parameters and left atrial diameter were obtained by echocardiography. Based on the values of deceleration time of early diastolic filling (DTE), and other diastolic parameters like left atrial diameter, all the patients were classified into three degrees of diastolic dysfunction. Our results showed that there was no group difference in distribution of gender, age, body mass index (BMI), VVI to DDD pacemakers implantation ratio, RNV parameters (LVEF, peak filling rate (PFR), time to PFR (TPFR)) and echocardiography parameters: LVEF and parameters of diastolic dysfunction. After 12 months of pacemaker stimulation, LVEF by RNV remained the same in the RVOT group 51.31±15.80% (P=0.75), and also in the RVA group 53.83±6.57%, (P=0.19). In the RVOT group the PFR was highly lower and this finding was significant (P=0.01), while TPFR was also significantly lower (P=0.03). By dividing the patients according to the degree of diastolic dysfunction we found that most patients in both groups at enrollment had a second degree diastolic dysfunction. In both groups diastolic dysfunction increased, the number of patients with third degree diastolic dysfunction increased, and the number of patients with second degree diastolic dysfunction decreased, however, the worsening of diastolic function was significant only in the RVOT group. In conclusion, pacemaker stimulation from RVOT, but not in RVA, leads to progression of diastolic dysfunction in patients with preserved LVEF. This negative effect of pacemaker stimulation from RVOT on diastolic parameters was confirmed by two independent methods, RNV and echocardiography.
我们的目的是分析左心室射血分数(LVEF)正常的患者在右心室流出道(RVOT)和右心室心尖(RVA)起搏刺激后的舒张期变化。这是一项前瞻性、随机、随访研究,持续了12个月。我们的研究纳入了132例连续植入永久性抗心动过缓起搏器的患者。根据右心室起搏导线位置,患者被分为两组:RVOT组——71例,右心室流出道起搏导线位置;RVA组——61例,右心室心尖起搏导线位置。我们测量了LVEF和舒张期参数:通过放射性核素心室造影(RNV)获得的峰值充盈率和达到峰值充盈率的时间。LVEF、各种舒张期参数和左心房直径通过超声心动图获得。根据舒张早期充盈减速时间(DTE)值以及左心房直径等其他舒张期参数,所有患者被分为三度舒张功能障碍。我们的结果显示,两组在性别、年龄、体重指数(BMI)、VVI与DDD起搏器植入比例、RNV参数(LVEF、峰值充盈率(PFR)、达到PFR的时间(TPFR))以及超声心动图参数:LVEF和舒张功能障碍参数方面的分布无差异。起搏器刺激12个月后,RNV测量的LVEF在RVOT组保持不变,为51.31±15.80%(P = 0.75),在RVA组也保持不变,为53.83±6.57%(P = 0.19)。在RVOT组,PFR显著降低(P = 0.01),TPFR也显著降低(P = 0.03)。根据舒张功能障碍程度对患者进行分组后,我们发现两组在入组时大多数患者为二度舒张功能障碍。两组舒张功能障碍均加重,三度舒张功能障碍患者数量增加,二度舒张功能障碍患者数量减少,然而,仅RVOT组舒张功能恶化具有统计学意义。总之,RVOT起搏刺激而非RVA起搏刺激会导致LVEF正常的患者舒张功能障碍进展。RVOT起搏刺激对舒张期参数的这种负面影响通过RNV和超声心动图这两种独立方法得到了证实。